These include irritable bowel syndrome, stomach ulcers, appendicitis, and Crohn's disease
10.1111/dom.15852 Summary Keywords DPP-4 activity, gastric inhibitory polypeptide, gastrointestinal motility, glucagon like peptide-1, type 2 diabetes mellitus Citation Malinauskas M, Stukas D, Rysevaite-Kyguoliene K, Gudaityte R, Kupinskas L, Casselbrant A, Jankauskaite L and Maleckas A (2026) Effects of GLP-1 and GIP on cholinergic-induced contractility in isolated jejunal muscle from obese patients with and without type 2 diabetes mellitus
Your Next Step Toward Safe and Effective GLP 1 Treatment GLP 1 medications offer a powerful and clinically supported path to meaningful weight loss, but the experience is always better with medical guidance
The nausea is typically worst during the first week at a new dose, particularly in the first day or two after your injection